Arrowstreet Capital Limited Partnership Increases Stock Position in Tenet Healthcare Corporation $THC

Key Points

• Arrowstreet Capital increased its stake in Tenet Healthcare by 57.4% in the first quarter, adding 244,901 shares to reach 671,700 shares valued at about $126.8 million.
• Tenet delivered a strong Q2, with EPS of $6.12 and revenue of $6.04 billion, both well above analyst expectations, helped by same-store revenue growth and expense control.
• Management also raised full-year 2026 EPS guidance to $20.30-$21.69, reinforcing optimism that the strong performance could continue beyond one quarter.

Arrowstreet Capital Limited Partnership increased its position in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 57.4% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 671,700 shares of the company's stock after purchasing an additional 244,901 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.78% of Tenet Healthcare worth $126,757,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in THC. Triumph Capital Management acquired a new stake in Tenet Healthcare in the 3rd quarter worth about $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare in the 4th quarter valued at $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter valued at approximately $29,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the second quarter worth about $35,000. Finally, Meeder Asset Management Inc. boosted its stake in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock valued at $38,000 after acquiring an additional 114 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on THC. Barclays boosted their price objective on Tenet Healthcare from $240.00 to $271.00 and gave the company an "overweight" rating in a research report on Friday. TD Cowen lowered their price objective on shares of Tenet Healthcare from $242.00 to $233.00 and set a "buy" rating on the stock in a research note on Monday, June 22nd. Guggenheim decreased their target price on Tenet Healthcare from $252.00 to $242.00 and set a "buy" rating for the company in a research report on Monday, July 20th. Stephens decreased their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an "overweight" rating for the company in a research report on Monday, May 4th. Finally, Morgan Stanley set a $254.00 target price on shares of Tenet Healthcare in a research report on Friday, May 1st. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $246.47.

Tenet Healthcare Stock Up 17.1%

Tenet Healthcare stock opened at $233.10 on Friday. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The company has a 50 day moving average of $185.16 and a 200-day moving average of $197.62. The stock has a market capitalization of $20.08 billion, a PE ratio of 8.99, a price-to-earnings-growth ratio of 1.93 and a beta of 1.27.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $6.12 EPS for the quarter, topping analysts' consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion during the quarter, compared to analysts' expectations of $5.43 billion. Tenet Healthcare had a return on equity of 27.17% and a net margin of 10.27%.Tenet Healthcare's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $4.02 earnings per share. On average, equities research analysts anticipate that Tenet Healthcare Corporation will post 21 EPS for the current fiscal year.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of the business's stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director directly owned 24,805 shares in the company, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of the business's stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.97% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.